Fintech Stock is Surging 70%

A social media-focused fintech stock is soaring in premarket trade, P&G is winning over budget-conscious shoppers with fresh product innovations, and Netflix is cashing in on record-breaking subscriber growth. Here’s what you need to know.

📲 Want our updates via text message? Get Elite Trade Club's pre-market insights and hottest stocks straight to your cell for 100% free. Click here to sign up.

Nasdaq IPO Alert

This recent Nasdaq IPO is quietly making waves, thanks to its 95% market share in a $240M aerospace niche.

With patented technology that integrates AI into smart glass, this company is poised for massive growth as the market races toward $124 billion by 2029.

Futures 📈

What to Watch

Earnings:

  • Procter & Gamble [PG]: Premarket

  • Johnson & Johnson [JNJ]: Premarket

  • Abbott Laboratories [ABT]: Premarket

  • Halliburton [HAL]: Premarket

  • Kinder Morgan [KMI]: Aftermarket

  • Discover Financial Services [DFS]: Aftermarket

Economic Reports:

  • U.S. Leading Economic Indicators (Dec): 10:00 a.m.

Consumer Goods

P&G Sees Sales Boost as Product Innovations Attract More U.S. Shoppers

Procter & Gamble released its second-quarter sales forecasts today, which are higher than analyst expectations. The firm believes its revenue is going to be driven by a resurgence in U.S. demand as the company’s strategic product innovations continue to resonate with a wider range of consumers.

The consumer goods giant introduced updated versions of its offerings at various price points, drawing in budget-conscious shoppers. As a result, P&G’s stock is climbing nearly 3% in premarket trading.

Following challenges posed by pandemic-era price increases that deterred some customers, P&G committed to expanding its product lineup with affordable options such as Olay Melts and Tide Evo. These efforts aim to attract cost-sensitive consumers who often opt for lower-priced store brands.

In recent months, the company also intensified its marketing efforts in China, leveraging the rising popularity of the Douyin shopping app. This initiative contributed to the growth of its Pantene hair care brand, helping it gain traction among Chinese consumers, executives previously reported.

During the quarter, P&G recorded a 2% increase in organic sales volume while pricing across its product range remained unchanged. The company's net sales climbed to $21.88 billion, surpassing analysts’ projections of $21.54 billion and outperforming last year’s $21.44 billion revenue.

Healthcare

Johnson & Johnson’s Cancer Drug Portfolio Fuels Quarterly Revenue Surge

Johnson & Johnson (J&J) reported higher-than-expected fourth-quarter sales and profits today, fueled by robust demand for its cancer medications. The company’s recent $14.6 billion acquisition of neurological drugmaker Intra-Cellular is expected to strengthen its pharmaceutical portfolio.

For 2025, J&J projects revenue between $90.9 billion and $91.7 billion, with adjusted earnings per share estimated at $10.75 to $10.95. These figures exceed analysts' expectations, which had forecasted revenue of $90.98 billion and earnings of $10.56 per share.

Fourth-quarter revenue reached $22.52 billion, marking a 5.3% increase from the previous year and surpassing estimates of $22.42 billion. Adjusted earnings for the quarter stood at $2.04 per share, slightly higher than the expected $2.01 despite a charge related to the acquisition of medical device maker V-Wave.

J&J’s oncology division saw a 19% rise in sales, led by its multiple myeloma drug Darzalex, which posted a 20.9% growth to exceed $3 billion. Meanwhile, sales from Carvykti, the company’s cancer cell therapy, outpaced projections, contributing $334 million for the quarter and $963 million for the year.

Following the spinoff of its consumer health division in 2023, J&J has been actively acquiring new businesses to bolster its pharmaceutical and medical device segments. Recent purchases include heart device firm Shockwave Medical, which added $258 million in quarterly revenue.

However, sales of the psoriasis treatment Stelara declined 14.7% in the fourth quarter as biosimilar competition intensified in international markets.

Next Big Bet

The $210B iGaming market is growing fast, with NJ leading the way.

This stock, with 60% revenue growth and a 20% retention rate, is perfectly positioned for explosive gains.

Entertainment

Netflix Ends 2024 with Historic Subscriber Growth, Raises Prices

Netflix shares are surging nearly 15% in premarket trading today after the streaming giant reported a record-breaking fourth-quarter performance, adding 18.9 million new subscribers and surpassing the 300 million mark globally.

The subscriber growth exceeded Wall Street expectations and set a new benchmark for the company, surpassing the previous record of 15 million additions in early 2020.

The company’s revenue for the quarter rose 16% year-over-year to $10.2 billion, marking its strongest growth since 2021. Netflix has announced plans to boost revenue by raising subscription prices in key markets, including the U.S., Canada, Portugal, and Argentina. The most popular U.S. plan is increasing to $17.99 per month.

Live programming contributed significantly to the surge in subscribers, with events like the Jake Paul vs. Mike Tyson boxing match and NFL games featuring Beyoncé attracting record sign-ups. Despite its initial slow start in advertising, Netflix reported that most new customers in its 12 ad-supported markets opted for the lower-cost tier.

The company forecasts Q1 2025 revenue of $10.4 billion and earnings of $5.58 per share, slightly below analyst expectations. Netflix has indicated this will be the last time it reports quarterly subscriber figures, shifting investor focus to revenue and profit metrics moving forward.

Movers and Shakers

Mobix Labs, Inc. [MOBX] - Last Close: $1.18

Mobix Labs, Inc. (NASDAQ: MOBX) is a fabless semiconductor company specializing in advanced connectivity solutions for next-gen communication systems, including 5G infrastructure and high-bandwidth cable applications.

The company's stock is up 23% in premarket trade because it is acquiring SCP Manufacturing, a Nevada-based producer of mission-critical electrical components for aerospace, defense, and commercial applications.

My Take: This is Mobix’s second acquisition in 60 days. The firm’s debt levels have gone up and free cash flow has severely declined this year. It might be best to see how the two acquisitions play out before investing here.

Critical Metals Corp. [CRML] - Last Close: $7.95

Critical Metals Corp. (CRML) is a mining exploration and development company focused on lithium and rare earth element deposits.

Its stock is surging 11% in premarket trade today after it announced a comprehensive Bitcoin treasury strategy. The firm will issue a convertible note financing of up to $500 million to purchase Bitcoin as a primary asset in its treasury program.

My Take: While investing in Bitcoin is extremely popular right now, the volatility of this strategy can be a cause of concern for CRML. Watch closely how this strategy plays out before investing.

Blackboxstocks Inc. [BLBX] - Last Close: $1.69

Blackboxstocks Inc. (BLBX) is a fintech and social media hybrid platform that offers real-time proprietary analytics and news for stock and options traders.

Its stock is surging by nearly 70% today after it secured financing from Five Narrow Lane LP today through senior debentures totaling $2.25 million. This financing is in anticipation of an impending merger between the firms.

My Take: If the merger goes through it could be a game changer for BLBX. Keep a close on this stock for further news.

Future of Flight

The electric aviation market is just taking off, and this company is at the forefront.

With significant revenue and strategic partnerships, this stock is poised to make a big impact.

Everything Else

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.

Best Regards,

— Adam Garcia
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.